"Why I've Ditched my UK Shares"



Investor Views: Private investor Andrew King has recently built a portfolio of higher-risk global and emerging market funds



READ SOURCE

READ  Addex, Janssen Pharma on go with Phase 2a study of JNJ-40411813 (ADX71149) in epilepsy

LEAVE A REPLY

Please enter your comment!
Please enter your name here